Author Login IJIRT Partner Network (IPN) Login

Human Serum Albumin: A Novel Drug Delivery Carrier System

  • Unique Paper ID: 168086
  • Volume: 11
  • Issue: 4
  • PageNo: 1281-1286
  • Abstract:
  • With the success of several clinical trials of products based on human serum albumin (HAS) and the rapid developments of nanotechnology, HAS-based Nano-drug delivery systems (HBNDSs) have received Extensive attention in the field of nano-medicine. However, there is still a lack of comprehensive reviews exploring the broader scope of HBNDSs in biomedical applications beyond cancer therapy. To address this gap, this review takes a systematic approach. Firstly, it focuses on the crystal structure and the potential binding sites of HAS. Additionally, it provides a comprehensive summary of recent progresses In the field of HBNDSs for various biomedical applications over the past five years, categorized according To the type of therapeutic drugs loaded onto HAS. These categories include small-molecule drugs, inorganic Materials and bioactive ingredients. Finally, the review summarizes the characteristics and current Application status of HBNDSs in drug delivery, and also discusses the challenges that need to be addressed for the clinical transformation of HS.
Download article email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 11
  • Issue: 4
  • PageNo: 1281-1286

Human Serum Albumin: A Novel Drug Delivery Carrier System

Related Articles

20 Oct, 2024

Exploring Pallets: A Cost Effective Carrier for Pharmaceutical Applications

Read More
Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry